Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

27. August 2024 06:04 ET | Quelle: Research and Markets

Antiemetic Drugs Strategic Research Report 2024-2030: Pharmacogenomics and Personalized Medicine Shape the Future of Developments, Rising Cancer Rates and Chemotherapy Demand Fuel Expansion

Dublin, Aug. 27, 2024 (GLOBE NEWSWIRE) -- The "Antiemetic Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Antiemetic Drugs...
18. August 2022 09:30 ET | Quelle: CMI

Global Gastroparesis Treatment Market to Surpass US$ 10,726.0 Million by 2030, Says Coherent Market Insights (CMI)

Seattle, Aug. 18, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global gastroparesis treatment market is estimated to be valued at US$ 8,061.9 million in 2022 and expected to...
03. November 2015 11:50 ET | Quelle: Neurogastrx

Neurogastrx Appoints Baxter Phillips III as President and Chief Executive Officer

CAMPBELL, Calif., Nov. 03, 2015 (GLOBE NEWSWIRE) -- Neurogastrx, a biopharmaceutical company engaged in developing novel drugs for gastrointestinal disorders, today announced the appointment of...